From: Feasibility of sustained response through long-term dosing in food allergy immunotherapy
Characteristics | ITT participants |
---|---|
Number of ITT participants | 46 |
Drop outs | 1 |
Followed up time in months after reaching 2 g maintenance dose in phase 1 trial, median (range)a | 48 (27–72) |
Sex, n (%) | |
Male | 24 (52%) |
Female | 22 (48%) |
Age in years, median (range) | 10.6 (6.4–46.9) |
With other atopic conditions (%) | |
Atopic dermatitis | 54 |
Atopic rhinitis | 56 |
Asthma | 56 |
Participants with number foods in OIT (n, %) | |
1 food | 21 (45.7%) |
2 foods | 7 (15.2%) |
3 foods | 9 (19.6%) |
4 foods | 3 (6.5%) |
5 foods | 6 (13%) |
Participants with certain food in OIT, n (%) | |
Almond | 5 (10.9%) |
Cashew | 13 (28.3%) |
Egg | 9 (19.6%) |
Hazelnut | 3 (6.5%) |
Milk | 8 (17.4%) |
Peanut | 38 (82.6%) |
Pecan | 8 (17.4%) |
Sesame | 5 (10.9%) |
Walnut | 15 (32.5%) |